{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:11:07Z","timestamp":1790172667170,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T00:00:00Z","timestamp":1437350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["2163540"],"award-info":[{"award-number":["2163540"]}]},{"name":"Career Development Fellowship","award":["565526"],"award-info":[{"award-number":["565526"]}]},{"name":"Senior Research Fellowship","award":["1064192"],"award-info":[{"award-number":["1064192"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI076398"],"award-info":[{"award-number":["1R01AI076398"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AI108255"],"award-info":[{"award-number":["RO1AI108255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI09320"],"award-info":[{"award-number":["R01AI09320"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Australian Government, Department of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.07.015","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T01:26:28Z","timestamp":1437182788000},"page":"4520-4525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["The potential impact of vaccination on the prevalence of gonorrhea"],"prefix":"10.1016","volume":"33","author":[{"given":"Andrew P.","family":"Craig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Apicella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Seib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.07.015_bib0275","series-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae (2012)","author":"WHO","year":"2012"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0280","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0285","series-title":"Antibiotic Resistance Threats in the United States, 2013","author":"CDC","year":"2013"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0290","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14787210.4.4.619","article-title":"Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies","volume":"4","author":"Tapsall","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0295","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0300","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2015.07.015_bib0305","doi-asserted-by":"crossref","first-page":"iv63","DOI":"10.1136\/sextrans-2013-051225","article-title":"Vaccine research for gonococcal infections: where are we?","volume":"89","author":"Jerse","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM197401172900301","article-title":"Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance","volume":"290","author":"Handsfield","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0315","series-title":"Sexually tramsitted diseases","first-page":"627","article-title":"Gonoccoal infection in the adult","author":"Hook","year":"2008"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0320","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases: the case for screening","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0325","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/sti.2009.037341","article-title":"A Bayesian approach to uncertainty analysis of sexually transmitted infection models","volume":"86","author":"Johnson","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0330","series-title":"Prevalence and incidence of selected sexually transmitted infections. Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis. Methods and results used by WHO to generate 2005 estimates","author":"WHO","year":"2011"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0335","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","article-title":"The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women","volume":"17","author":"Edwards","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0340","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.1986.03370150104037","article-title":"The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle","volume":"255","author":"Sweet","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0345","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/513820","article-title":"Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases","volume":"177","author":"Levine","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0350","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(97)02190-9","article-title":"Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0355","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00002030-200303070-00019","article-title":"Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae","volume":"17","author":"Chen","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0360","series-title":"Committee on Prevention and Control of Sexually Transmitted Diseases","first-page":"1","article-title":"The Hidden Epidemic: Confronting Sexually Transmitted Diseases","author":"Eng","year":"1997"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0365","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/598983","article-title":"Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection","volume":"199","author":"Gray","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0370","series-title":"Global incidence and prevalence of selected curable sexually transmitted infections\u20142008","author":"WHO","year":"2012"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0375","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a009820","article-title":"Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae","volume":"149","author":"Fox","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0380","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00007435-200110000-00001","article-title":"Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers","volume":"28","author":"Schmidt","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0385","first-page":"367","article-title":"Serovar specific immunity to Neisseria gonorrhoeae: does it exist?","volume":"71","author":"Ross","year":"1995","journal-title":"Genitourin Med"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0390","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature","volume":"36","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0395","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/oxfordjournals.aje.a121125","article-title":"An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females","volume":"91","author":"Holmes","year":"1970","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0400","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/oxfordjournals.aje.a112597","article-title":"Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men","volume":"108","author":"Hooper","year":"1978","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0405","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1001\/jama.1983.03340230057031","article-title":"Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea","volume":"250","author":"Platt","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0410","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1086\/314485","article-title":"Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners","volume":"178","author":"Lin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0415","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nbt1207-1361","article-title":"Bridging the knowledge gaps in vaccine design","volume":"25","author":"Rappuoli","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0420","series-title":"New generation vaccines","first-page":"755","article-title":"Vaccines against gonoccoal infection","author":"Mietzner","year":"2004"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0425","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.vaccine.2013.08.067","article-title":"Vaccines against gonorrhea: current status and future challenges","volume":"32","author":"Jerse","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0430","series-title":"Neisseria: molecular mechanisms of pathogenesis","first-page":"195","article-title":"Difficulties in developing neisserial vaccines","author":"Seib","year":"2010"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmicb.2011.00052","article-title":"New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host","volume":"2","author":"Liu","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0440","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1172\/JCI38330","article-title":"Vaccinology in the genome era","volume":"119","author":"Rinaudo","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0445","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ: Br Med J"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0450","series-title":"Sexually transmitted diseases surveillance 2013","author":"CDC","year":"2014"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0455","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007435-197804000-00003","article-title":"Dynamics and control of the transmission of gonorrhea","volume":"5","author":"Yorke","year":"1978","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0460","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/169.3.532","article-title":"Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development","volume":"169","author":"Cohen","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0465","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.vaccine.2013.11.007","article-title":"The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and disease","volume":"32","author":"Garnett","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0470","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.vaccine.2013.11.070","article-title":"Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program","volume":"32","author":"Paul","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinthera.2013.12.005","article-title":"The Australian experience with the human papillomavirus vaccine","volume":"36","author":"Garland","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0480","first-page":"301","article-title":"Rubella vaccines: WHO position paper","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0485","first-page":"27","article-title":"BCG vaccine. WHO position paper","volume":"79","author":"WHO","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0495","first-page":"198","article-title":"Tetanus vaccine, WHO position paper","volume":"81","author":"WHO","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0500","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1071\/SH13205","article-title":"Epidemiology of gonorrhoea notifications in Australia, 2007\u201312","volume":"11","author":"Roberts-Witteveen","year":"2014","journal-title":"Sex Health"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2015.07.015_bib0505","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/cir696","article-title":"Sexually transmitted diseases in men who have sex with men","volume":"53","author":"Mayer","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0510","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1128\/JCM.05341-11","article-title":"Differing Neisseria gonorrhoeae bacterial loads in the pharynx and rectum in men who have sex with men: implications for gonococcal detection, transmission, and control","volume":"49","author":"Bissessor","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0515","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group","volume":"342","author":"Quinn","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0520","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(08)61115-0","article-title":"Relation between HIV viral load and infectiousness: a model-based analysis","volume":"372","author":"Wilson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0525","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/431978","article-title":"Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads","volume":"41","author":"Bleeker","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0530","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1473-3099(07)70137-8","article-title":"Trachoma: transmission, infection, and control","volume":"7","author":"Gambhir","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0535","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.annepidem.2011.11.005","article-title":"Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links","volume":"22","author":"Gallo","year":"2012","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.vaccine.2015.07.015_bib0540","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/IAI.19.2.704-710.1978","article-title":"Inhibition of Neisseria gonorrhoeae by aerobic and facultatively anaerobic components of the endocervical flora: evidence for a protective effect against infection","volume":"19","author":"Saigh","year":"1978","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:08:37Z","timestamp":1652879317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":54,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15009494"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential impact of vaccination on the prevalence of gonorrhea","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}